Dr. Bansal has been on faculty at Mount Sinai since 2001. In addition to an NIH-funded research program focused on molecular mechanisms of liver fibrosis — with seminal contributions to understanding liver fibrosis in people living with HIV — she held numerous leadership roles including Transplant Hepatology Fellowship Director, CMO of Mount Sinai Care LLC, Deputy CMO for Mount Sinai Health Partners, and VP of Population Health for Quality and Efficiency. She has served as PI for numerous MASH/NASH clinical trials and as Secretary of AASLD. In January 2024, Dr. Bansal was named System Chief, Division of Liver Diseases for the Mount Sinai Health System.